(VIANEWS) – Shares of Viking Therapeutics (NASDAQ: VKTX) slid 6.96% to $3.55 at 15:06 EST on Tuesday, after five consecutive sessions in a row of losses. NASDAQ is rising 0.63% to $13,855.10, following the last session’s upward trend. This seems, at the moment, a somewhat bullish trend trading session today.
Viking Therapeutics’s last close was $3.56, 64.72% below its 52-week high of $10.09.
Today’s last reported volume for Viking Therapeutics is 791599 which is 10.49% below its average volume of 884467.
The company’s growth estimates for the current quarter and the next is a negative 61.5% and a negative 46.7%, respectively.
Viking Therapeutics’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.70%, a negative 1.28%, and a positive 2.88%, respectively.
Viking Therapeutics’s highest amplitude of average volatility was 2.70% (last week), 3.29% (last month), and 2.88% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Viking Therapeutics’s stock is considered to be overbought (>=80).
Viking Therapeutics’s Stock Yearly Top and Bottom Value
Viking Therapeutics’s stock is valued at $3.55 at 15:06 EST, way under its 52-week low of $4.81.
Viking Therapeutics’s Moving Average
Viking Therapeutics’s value is way under its 50-day moving average of $5.82 and way below its 200-day moving average of $6.03.
More news about Viking Therapeutics (VKTX).